Sign In
Buy RXST
$4.79
-0.150 (-3.04%)
At Close: Jun 03, 2026
Carnegie Lake Advisors LLC Purchases 87,345 Shares of RxSight, Inc. $RXST
05:42am, Wednesday, 31'st Dec 2025
Carnegie Lake Advisors LLC boosted its position in shares of RxSight, Inc. (NASDAQ: RXST) by 81.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commis
RxSight, Inc. Announces Chief Financial Officer Transition
05:15pm, Monday, 22'nd Dec 2025
ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
Thrivent Financial for Lutherans Lowers Holdings in RxSight, Inc. $RXST
05:05am, Sunday, 21'st Dec 2025
Thrivent Financial for Lutherans decreased its holdings in RxSight, Inc. (NASDAQ: RXST) by 30.9% in the second quarter, according to the company in its most recent disclosure with the Securities and E
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
04:05pm, Thursday, 20'th Nov 2025
ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized visi
RxSight, Inc. (RXST) Q3 2025 Earnings Call Transcript
08:51pm, Wednesday, 05'th Nov 2025
RxSight, Inc. ( RXST ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Oliver Moravcevic Ronald Kurtz - Co-President, CEO & Director Shelley Thunen - Co-President & CFO Confere
RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates
07:51pm, Wednesday, 05'th Nov 2025
RxSight, Inc. (RXST) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to break-even earnings per share a year ago.
RxSight, Inc. Reports Third Quarter 2025 Financial Results
04:05pm, Wednesday, 05'th Nov 2025
ALISO VIEJO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin
Y Intercept Hong Kong Ltd Invests $1.43 Million in RxSight, Inc. $RXST
03:41am, Monday, 03'rd Nov 2025
Y Intercept Hong Kong Ltd acquired a new position in RxSight, Inc. (NASDAQ: RXST) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Comm
RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025
04:05pm, Wednesday, 22'nd Oct 2025
ALISO VIEJO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followi
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
04:05pm, Thursday, 16'th Oct 2025
ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ca
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In RxSight (RXST) To Contact Him Directly To Discuss Their Options If you are a long-term s
NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or the "Company")(NASDAQ: RXST).
Shareholders of RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights – RXST
03:48pm, Monday, 22'nd Sep 2025
NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
02:18pm, Monday, 22'nd Sep 2025
NEW YORK--(BUSINESS WIRE)---- $RXST #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company
RXSIGHT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Urges RXST To Contact the Firm Regarding Class Action Lawsuit
10:03am, Monday, 22'nd Sep 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In RxSight (RXST) To Contact Him Directly To Discuss Their Options If you purchased or acquir
